{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:03:35Z","timestamp":1793628215980,"version":"4.5.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>MYH9-related diseases (MYH9-RD) are autosomal dominant disorders caused by mutations of the MYH9 gene encoding the non-muscle myosin heavy chain IIA. They are characterized by congenital thrombocytopenia, giant platelets and leucocyte inclusions. Hearing impairment, pre-senile cataract and nephropathy can also occur. We aimed to evaluate renal involvement and outcome in MYH9-RD patients followed-up by nephrologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicentre observational study of 13 patients among 9 families with MYH9 mutation diagnosed by genetic testing and immunofluorescence assay referred to nephrologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At initial referral, median age was 30 (range 14\u201376) years. Median estimated glomerular filtration rate was 66\u2009mL\/min\/1.73\u00a0m2 (0\u2013141) and two patients had already end-stage renal disease (ESRD). Renal presentation associated proteinuria (n\u2009=\u200912), haematuria (n\u2009=\u20096) and hypertension (n\u2009=\u20096). Three patients developed a rapid onset ESRD whereas five others had a relatively stable kidney function over a 3-year median follow-up (1\u201334). Extra-renal features varied widely, with hearing impairment in six patients, cataract in two and mild liver dysfunction in seven. Thrombocytopenia existed at referral in 11 patients. Time to diagnosis varied from 0 to 29\u2009years (median 3\u2009years). Initial diagnoses such as idiopathic thrombocytopenic purpura (n\u2009=\u20094) and focal segmental glomerulosclerosis (n\u2009=\u20091) led to corticosteroid administration (n\u2009=\u20094), intravenous immunoglobulins (n\u2009=\u20093), cyclophosphamide (n\u2009=\u20091) and splenectomy (n\u2009=\u20091).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Renal involvement and outcome in MYH9-RD are heterogeneous. The diagnosis is often delayed and misdiagnoses can lead to unnecessary treatments. MYH9-RD should be considered in any patient with glomerular involvement associated with a low or slightly decreased platelet count and\/or hearing loss and liver dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfy117","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T15:12:24Z","timestamp":1541517144000},"page":"494-502","source":"Crossref","is-referenced-by-count":39,"title":["MYH9-related disorders display heterogeneous kidney involvement and outcome"],"prefix":"10.1093","volume":"12","author":[{"given":"Nahid","family":"Tabibzadeh","sequence":"first","affiliation":[{"name":"Explorations Fonctionnelles R\u00e9nales, APHP H\u00f4pital Bichat, DHU FIRE, CRI-Inserm U1149 et Universit\u00e9 Paris Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Fleury","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie et M\u00e9decine Interne, CH Valenciennes, Valenciennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Labatut","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie, CH Niort, Niort, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bridoux","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie, CHU Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lionet","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie, CHRU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Jourde-Chiche","sequence":"additional","affiliation":[{"name":"Aix-Marseille Univ, C2VN, INSERM 1263-INRA 1260, and AP-HM, Centre de N\u00e9phrologie et Transplantation R\u00e9nale, H\u00f4pital de la Conception, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vrtovsnik","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie, APHP H\u00f4pital Bichat, DHU FIRE, CRI-Inserm U1149 et Universit\u00e9 Paris Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schlegel","sequence":"additional","affiliation":[{"name":"CRCMH Pathologies Plaquettaires Robert Debr\u00e9, APHP H\u00f4pital Robert Debr\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vanhille","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie et M\u00e9decine Interne, CH Valenciennes, Valenciennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"2019080108303109900_sfy117-B1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1220327","article-title":"MYH9-related platelet disorders","volume":"35","author":"Althaus","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"2019080108303109900_sfy117-B2","first-page":"439","article-title":"Gleichzeitige konstitutionelle Veranderungen an Neutrophilen und Thrombozyten","volume":"12","author":"Hegglin","year":"1945","journal-title":"Helv Med Acta"},{"key":"2019080108303109900_sfy117-B3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1182\/blood.V32.6.950.950","article-title":"The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies","volume":"32","author":"Lusher","year":"1968","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(72)90017-4","article-title":"Hereditary macrothrombocytopathia, nephritis and deafness","volume":"52","author":"Epstein","year":"1972","journal-title":"Am J Med"},{"key":"2019080108303109900_sfy117-B5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V65.2.397.397","article-title":"Fechtner syndrome\u2013a variant of Alport\u2019s syndrome with leukocyte inclusions and macrothrombocytopenia","volume":"65","author":"Peterson","year":"1985","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF01732878","article-title":"Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions","volume":"61","author":"Greinacher","year":"1990","journal-title":"Blut"},{"key":"2019080108303109900_sfy117-B7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/79063","article-title":"Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin\/Fechtner Syndrome Consortium","volume":"26","author":"Seri","year":"2000","journal-title":"Nat Genet"},{"key":"2019080108303109900_sfy117-B8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/324267","article-title":"Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes","volume":"69","author":"Heath","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2019080108303109900_sfy117-B9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mgg3.68","article-title":"Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders","volume":"2","author":"Saposnik","year":"2014","journal-title":"Mol Genet Genomic Med"},{"key":"2019080108303109900_sfy117-B10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/humu.22476","article-title":"MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations","volume":"35","author":"Pecci","year":"2014","journal-title":"Hum Mutat"},{"key":"2019080108303109900_sfy117-B11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/humu.20661","article-title":"Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease","volume":"29","author":"Pecci","year":"2008","journal-title":"Hum Mutat"},{"key":"2019080108303109900_sfy117-B12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.2010.21","article-title":"Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease","volume":"78","author":"Sekine","year":"2010","journal-title":"Kidney Int"},{"key":"2019080108303109900_sfy117-B13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00467-010-1735-3","article-title":"Renal manifestations of patients with MYH9-related disorders","volume":"26","author":"Han","year":"2011","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"2019080108303109900_sfy117-B14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V97.4.1147","article-title":"Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly\/Sebastian syndrome)","volume":"97","author":"Kunishima","year":"2001","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ckj\/sft094","article-title":"Myosin heavy chain-9-related disorders (MYH9-RD): a case report","volume":"6","author":"Vassallo","year":"2013","journal-title":"Clin Kidney J"},{"key":"2019080108303109900_sfy117-B16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ki.2010.82","article-title":"Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?","volume":"78","author":"Kopp","year":"2010","journal-title":"Kidney Int"},{"key":"2019080108303109900_sfy117-B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ajcp\/72.1.111","article-title":"Alport\u2019s syndrome associated with macrothrombopathic thrombocytopenia","volume":"72","author":"Clare","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"2019080108303109900_sfy117-B18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00856828","article-title":"Hereditary nephritis, platelet disorders and deafness-Epstein\u2019s syndrome","volume":"6","author":"T\u00fari","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"2019080108303109900_sfy117-B19","first-page":"62","article-title":"[A case report of Epstein syndrome]","volume":"37","author":"Iyori","year":"1995","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"2019080108303109900_sfy117-B20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s004670050700","article-title":"End-stage renal disease in two pediatric patients with Fechtner syndrome","volume":"13","author":"Moxey-Mims","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"2019080108303109900_sfy117-B21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jcp.50.11.919","article-title":"Normal distribution of collagen IV in renal basement membranes in Epstein\u2019s syndrome","volume":"50","author":"Naito","year":"1997","journal-title":"J Clin Pathol"},{"key":"2019080108303109900_sfy117-B22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/ajkd.2003.50028","article-title":"Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)","volume":"41","author":"Ghiggeri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2019080108303109900_sfy117-B23","first-page":"1076","article-title":"Epstein syndrome with rapid progression to end stage renal disease","volume":"20","author":"Alhindawi","year":"2009","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"2019080108303109900_sfy117-B24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08860220903033708","article-title":"Epstein syndrome presenting as renal failure in young patients","volume":"31","author":"Yap","year":"2009","journal-title":"Ren Fail"},{"key":"2019080108303109900_sfy117-B25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00277-011-1370-5","article-title":"A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts","volume":"91","author":"Hao","year":"2012","journal-title":"Ann Hematol"},{"key":"2019080108303109900_sfy117-B26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000342123","article-title":"Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease","volume":"129","author":"Sun","year":"2013","journal-title":"Acta Haematol"},{"key":"2019080108303109900_sfy117-B27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.transproceed.2013.11.144","article-title":"Successful renal transplantation in MYH9-related disorder with severe macrothrombocytopenia: first report in Korea","volume":"46","author":"Min","year":"2014","journal-title":"Transplant Proc"},{"key":"2019080108303109900_sfy117-B28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.krcp.2014.09.003","article-title":"MYH9 nephropathy","volume":"34","author":"Oh","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"2019080108303109900_sfy117-B29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","volume":"31","author":"Gast","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2019080108303109900_sfy117-B30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1523-1755.2004.00560.x","article-title":"Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene","volume":"65","author":"Pescucci","year":"2004","journal-title":"Kidney Int"},{"key":"2019080108303109900_sfy117-B31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.md.0000076006.64510.5c","article-title":"MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness","volume":"82","author":"Seri","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2019080108303109900_sfy117-B32","first-page":"312","article-title":"The May-Hegglin anomaly in a kidney transplant recipient","volume":"3","author":"Fabbian","year":"2010","journal-title":"NDT Plus"},{"key":"2019080108303109900_sfy117-B33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.2830400311","article-title":"Coincidental finding of May-Hegglin anomaly in a patient with end-stage renal failure","volume":"40","author":"Nel","year":"1992","journal-title":"Am J Hematol"},{"key":"2019080108303109900_sfy117-B34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s002770000286","article-title":"Familial occurrence of the May-Hegglin anomaly: is the accompanying renal failure part of a new subentity?","volume":"80","author":"Demeter","year":"2001","journal-title":"Ann Hematol"},{"key":"2019080108303109900_sfy117-B35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1590\/2175-8239-jbn-3879","article-title":"Macrothrombocytopenia, renal dysfunction and nephrotic syndrome in a young male patient: a case report of MYH9-related disease","volume":"40","author":"Sevignani","year":"2018","journal-title":"J Bras Nefrol"},{"key":"2019080108303109900_sfy117-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"2019080108303109900_sfy117-B37","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2017121260","article-title":"The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort Study","volume":"29","author":"Srivastava","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2019080108303109900_sfy117-B38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2003-05-1742","article-title":"Inherited thrombocytopenia: when a low platelet count does not mean ITP","volume":"103","author":"Drachman","year":"2004","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B39","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2007-08-105460","article-title":"My, oh Myh9 \u2026 and platelets, too","volume":"110","author":"Shivdasani","year":"2007","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B40","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2007-03-080184","article-title":"Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion","volume":"110","author":"L\u00e9on","year":"2007","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B41","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2010-08-304725","article-title":"Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations","volume":"116","author":"Pecci","year":"2010","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B42","first-page":"891","article-title":"In vitro and in vivo effects of desmopressin on platelet function","volume":"84","author":"Balduini","year":"1999","journal-title":"Haematologica"},{"key":"2019080108303109900_sfy117-B43","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2011-08-373811","article-title":"Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD","volume":"119","author":"L\u00e9on","year":"2012","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B44","doi-asserted-by":"crossref","first-page":"e35986","DOI":"10.1371\/journal.pone.0035986","article-title":"Alteration of liver enzymes is a feature of the MYH9-related disease syndrome","volume":"7","author":"Pecci","year":"2012","journal-title":"PloS One"},{"key":"2019080108303109900_sfy117-B45","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1128\/MCB.05234-11","article-title":"Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy","volume":"31","author":"Johnstone","year":"2011","journal-title":"Mol Cell Biol"},{"key":"2019080108303109900_sfy117-B46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1681\/ASN.V13165","article-title":"Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes","volume":"13","author":"Arrondel","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2019080108303109900_sfy117-B47","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1182\/blood-2005-07-2961","article-title":"The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin","volume":"107","author":"Huang","year":"2006","journal-title":"Blood"},{"key":"2019080108303109900_sfy117-B48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood-2011-06-358853","article-title":"Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/12\/4\/494\/29027332\/sfy117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T08:21:52Z","timestamp":1662366112000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/12\/4\/494\/5250852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12,17]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy117","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2018,12,17]]}}}